WAM
GILD icon

Wakefield Asset Management’s Gilead Sciences GILD Stock Holding History

Wakefield Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-30,860
Closed -$4.3M – 233
2026
Q1 		$4.3M Sell
30,860
-109
-0.4% -$15.3K 1.14% 21
2025
Q4 		$3.8M Sell
30,969
-377
-1% -$45.8K 1.03% 33
2025
Q3 		$3.48M Sell
31,346
-2,422
-7% -$275K 0.95% 35
2025
Q2 		$3.74M Sell
33,768
-813
-2% -$86.5K 1.05% 27
2025
Q1 		$3.87M Buy
34,581
+29,020
+522% +$2.99M 1.17% 15
2024
Q4 		$514K Buy
+5,561
New +$501K 0.17% 131
2023
Q2 		– Sell
-34,548
Closed -$2.87M – 164
2023
Q1 		$2.87M Buy
34,548
+180
+0.5% +$14.9K 1.19% 22
2022
Q4 		$2.95M Buy
34,368
+29,099
+552% +$2.3M 1.25% 18
2022
Q3 		$325K Sell
5,269
-62
-1% -$3.91K 0.15% 135
2022
Q2 		$330K Buy
+5,331
New +$330K 0.14% 138
2019
Q4 		– Sell
-3,181
Closed -$202K – 170
2019
Q3 		$202K Sell
3,181
-95
-3% -$6.21K 0.09% 147
2019
Q2 		$221K Buy
+3,276
New +$216K 0.09% 145

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wakefield Asset Management's GILD Position: Q2 2026 in Review

Wakefield Asset Management sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 30,860 shares — an estimated $4.3M sold.

Wakefield Asset Management first reported a position in GILD in Q2 2019 and held it in 12 quarters. The position peaked at $4.3M in Q1 2026. 2,279 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Wakefield Asset Management reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Wakefield Asset Management sold 30,860 Gilead Sciences shares in Q2 2026, an estimated $4.3M.
  • Wakefield Asset Management first reported a position in Gilead Sciences in Q2 2019 and held it in 12 quarters.
  • Wakefield Asset Management's Gilead Sciences position peaked at $4.3M in Q1 2026.
  • 2,279 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Wakefield Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.